<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" ><generator uri="https://jekyllrb.com/" version="4.3.2">Jekyll</generator><link href="/preview/pr-13/feed.xml" rel="self" type="application/atom+xml" /><link href="/preview/pr-13/" rel="alternate" type="text/html" /><updated>2023-06-04T01:52:56+00:00</updated><id>/preview/pr-13/feed.xml</id><title type="html">Penter Lab</title><subtitle>Understanding cancer and immune cell interactions using large-scale single cell genomics approaches.</subtitle><entry><title type="html">Funding from BIH Charité Digital Clinician Scientist Program</title><link href="/preview/pr-13/2023/05/31/Funding-from-BIH-DCSP.html" rel="alternate" type="text/html" title="Funding from BIH Charité Digital Clinician Scientist Program" /><published>2023-05-31T00:00:00+00:00</published><updated>2023-06-04T01:52:05+00:00</updated><id>/preview/pr-13/2023/05/31/Funding-from-BIH%20DCSP</id><content type="html" xml:base="/preview/pr-13/2023/05/31/Funding-from-BIH-DCSP.html"><![CDATA[<p>We are grateful for research funding from the BIH Charité Digital Clinician Scientist Program
that will provide Livius with 50% protected research time for a period of 3 years.<br />
A big thank you to Prof. Dr. med. Frederik Damm and Prof. Dr. rer. nat. Nils Blüthgen 
for supporting the application!</p>]]></content><author><name>Livius Penter</name></author><category term="funding" /><category term="digital medicine" /><summary type="html"><![CDATA[We are grateful for research funding from the BIH Charité Digital Clinician Scientist Program that will provide Livius with 50% protected research time for a period of 3 years. A big thank you to Prof. Dr. med. Frederik Damm and Prof. Dr. rer. nat. Nils Blüthgen for supporting the application!]]></summary></entry></feed>